Safety Considerations When Combining Ashwagandha and Semaglutide No major direct pharmacokinetic interactions exist between ashwagandha and semaglutide, but several indirect effects warrant attention
20 Its target, thyroid hormone receptor beta, is predominantly expressed in the liver: apparently, even people with normal thyroid hormone levels systemically can have intrahepatic hypothyroidism, leading to hepatic steatosis and inflammation, which this drug can counteract
This ensures a comprehensive review of your medication regimen and allows healthcare professionals to provide personalised advice based on your medical history, current health status, and any other medications you may be taking concurrently
Through downregulating monocyte chemoattractant protein-1 expression, semaglutide treatment, an FDA-approved GLP-1 RA medicine targeting Type II diabetes mellitus (T2DM) (Christou et al., 2019), inhibited monocyte migration and infiltration from the circulatory system to inflammatory regions (Pontes-da-Silva et al., 2022)